Share Name Share Symbol Market Type Share ISIN Share Description
Standard Life Aberdeen Plc LSE:SLA London Ordinary Share GB00BF8Q6K64 ORD 13 61/63P
  Price Change % Change Share Price Shares Traded Last Trade
  -5.30 -1.76% 296.20 3,875,820 16:35:10
Bid Price Offer Price High Price Low Price Open Price
296.50 296.70 304.30 296.30 301.70
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 3,609.00 838.00 38.50 7.7 6,674
Last Trade Time Trade Type Trade Size Trade Price Currency
18:10:34 O 20,315 297.49 GBX

Standard Life Aberdeen (SLA) Latest News

More Standard Life Aberdeen News
Standard Life Aberdeen Investors    Standard Life Aberdeen Takeover Rumours

Standard Life Aberdeen (SLA) Discussions and Chat

Standard Life Aberdeen Forums and Chat

Date Time Title Posts
07/4/202114:36Standard Life SLA2,585
07/4/202109:42Standard Life Aberdeen PLC434
06/4/202014:06Standard Life Thread Post AAM Merger32
04/4/202011:23Standard Life Aberdeen pension fund, trading without SIPP6
11/12/201810:25Profit Warning ? Market Cap loss Ј 5.5 billion ++-

Add a New Thread

Standard Life Aberdeen (SLA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-04-12 17:28:46297.4920,31560,435.09O
2021-04-12 17:10:46296.202,8418,415.04O
2021-04-12 17:10:35296.204,49213,305.30O
2021-04-12 17:04:09298.30150447.45O
2021-04-12 16:58:13296.209832,911.65O
View all Standard Life Aberdeen trades in real-time

Standard Life Aberdeen (SLA) Top Chat Posts

Standard Life Aberdeen Daily Update: Standard Life Aberdeen Plc is listed in the General Financial sector of the London Stock Exchange with ticker SLA. The last closing price for Standard Life Aberdeen was 301.50p.
Standard Life Aberdeen Plc has a 4 week average price of 280.80p and a 12 week average price of 280.80p.
The 1 year high share price is 332.80p while the 1 year low share price is currently 201.40p.
There are currently 2,253,362,623 shares in issue and the average daily traded volume is 3,590,401 shares. The market capitalisation of Standard Life Aberdeen Plc is £6,674,460,089.33.
spud: Standard Life Aberdeen simplifies Phoenix Group partnership In February 2018, SLA announced the sale of its insurance business for £3.24bn, as part of a long-term strategic partnership with Phoenix. The original transaction was highly complex and included a provision for Phoenix to license the Standard Life brand, while SLA would provide the aligned marketing services in perpetuity. Today’s announcement significantly simplifies the arrangements for the Standard Life brand and related marketing. The strategic asset management partnership - under which SLA currently manages £147.4bn of Phoenix assets - will be extended until at least 2031. To support growth plans for SLA's Wrap and Elevate adviser platforms, it will purchase the Wrap self-invested personal pension (SIPP) and Wrap Onshore Bond businesses from Phoenix. SLA will acquire the trustee investment plan (TIP) business from Phoenix Group to consolidate its investments offering for UK pension scheme clients. It will also sell the Standard Life brand to Phoenix during the course of 2021. As a consequence, certain colleagues who support this brand and related marketing will also transfer to Phoenix. SLA will pay £32m to Phoenix in return for it bearing the cost of some transferring colleagues going forward. SLA has initiated a branding review, the outcome of which it will announce later this year. The upfront payment by SLA for the purchase of the Wrap SIPP, onshore bond and TIP businesses will be £62.5m, which will be offset in part by expected payments from Phoenix to SLA relating to the profits of the business prior to completion of the legal transfer. All outstanding differences between the two groups in relation to legacy matters have been settled as part of the agreements being announced today. The resolution of these legacy matters will not materially impact on SLA’s 2020 financial performance and should result in a net cash inflow of £34m this month. This represents an inflow of £54m relating to specific indemnities and a £20m outflow relating to settlement of other legacy matters. SLA’s shareholding in Phoenix remains around 14% and it retains the right to appoint a director to the Phoenix board. SLA chief executive Stephen Bird said: "What we are announcing today is an agreement that simplifies the relationships in a way that will allow us to work together constructively as partners for at least the next 10 years. “The Standard Life brand has an important heritage - in the UK, it has strong recognition as a life insurance and workplace pensions brand - this is closely aligned with Phoenix’s strategy and customer base. "This is much less the case with the business we are building at Standard Life Aberdeen which is focused on global asset management, our market-leading platforms offerings to UK financial advisers and their customers, and our UK savings and wealth businesses.” Phoenix chief executive Andy Briggs added: “The simplification of the Standard Life brand, sales and marketing will be a key enabler of Phoenix’s growth strategy, which in turn should lead to greater asset flows to ASI.” spud
chinese investor: From FT :- British Steel’s intake of apprentices in 1983 included an ambitious Scot keen to make his mark. After qualifying as an engineer, Stephen Bird eventually switched from steelmaking to finance and spent two decades at Citigroup, rising to senior roles in Asia and head of its global consumer banking unit.  The 53-year-old made another career switch last year when he became chief executive of Standard Life Aberdeen and immediately began reorganising the underperforming £456bn Edinburgh-based asset manager. “Few companies survive into their third century,” he says of SLA, which traces its roots back to 1825. “But my ambition is to ensure that Standard Life Aberdeen is a competitor fit for the 21st century.” During a video call from company headquarters, he is not shy about discussing his achievements, pointing out during his Citigroup years he “built the biggest wealth asset management business in Asia”. A recent SLA alumni, who notes Bird was in the mix as a possible chief executive for HSBC, described him as “very driven”. Bird’s plan is to strengthen SLA’s institutional investment and adviser platforms, expand wealth management and the fledgling direct-to-consumer business and deepen relationships with strategic partners such as Phoenix Insurance. “We have to set our sights higher. We have to focus, do fewer things more effectively, and create a performance culture in order to grow this business.” Such improvements are badly needed. SLA’s market value has shrunk by almost half from a peak of £13.3bn in October 2017 to £6.8bn following the combination of Standard Life with Aberdeen Asset Management. The deal devised by Keith Skeoch and Martin Gilbert, former SLA co-chiefs, was supposed to create a world class investment company but massive investor withdrawals and a drop of more than 40 per cent in pre-tax profits have resulted. Stemming investor outflows is a top priority. Bank of America forecasts net outflows of £10bn for 2020, which would lift withdrawals over the past four years to close to £100bn. Bird has pushed through a series of changes in his first six months as chief executive which has unsettled some staff. “Everybody is on guard. He is shaking things up quite substantially, including the organisational structure and operating tempo. It all feels very different but in quite a new and exciting way,” said an employee who declined to be named. But Bird insists that staff were frustrated by the lack of progress under the previous regime and improvements in morale will follow. “We now have the right people, the right technology and, most importantly, a lock on clients’ needs and ambitions,” says Bird. SLA’s shares currently yield about 6.9 per cent, one of the highest payout ratios among FTSE 100 peers. A thorny question confronting the board is whether to cut the dividend, which is uncovered by earnings. SLA’s robust balance sheet means it could match the 21.6p full-year dividend paid in 2019 but longer term support could be problematic. Some analysts think it would be timely to reduce the dividend by half given the cuts in payouts forced on numerous other companies by the coronavirus pandemic. Bird would not be drawn on this sensitive topic ahead of SLA’s full-year results in March. Since his arrival, the £6.5bn Parmenion advisory business, which was bought for £50m in 2016, has been put up for sale; the Nordic direct real estate business was sold last year; and SLA is quitting Indonesia, a fast growing market where it hoped to become a top 10 player but failed to penetrate. Tighter focus should deliver cost savings. SLA’s cost to income ratio stands at 85 per cent, exceeded only by Credit Suisse AM and GAM in a group of 34 rival European asset management businesses, according to analysts. Under Bird, a single asset management platform to oversee all of SLA’s institutional investment business will be completed this year. New fund development will be centralised instead of being carried out in multiple locations. Bird hints a new distribution partnership with a global wealth platform will be unveiled in the coming weeks. He declines to answer whether the partner is Citigroup but also struggles to suppress a smile. Speculation is also rife about mergers and acquisitions across the investment industry. SLA holds £1.8bn of surplus capital on its balance sheet which it could use to finance deals. But Bird is cautious. “We are going to be very careful if and when we acquire anything.” Cold water is poured over press reports over the scale of his ambitions to compete against the giant ETF businesses established by BlackRock and Vanguard. “We have to participate in ETFs when they are the most efficient delivery mechanism. We have more new ETFs in the pipeline but we are not going to become a 5 basis points index fund provider,” he says. Bird also aims to create a single integrated wealth management platform that will combine SLA’s financial advice and planning service which is branded as 1825, a discretionary fund management unit with £8bn in assets and SLA Choices, a fledgling consumer savings unit.  “Asset management and wealth management are converging across the world. Intermediaries are being squeezed out and everyone is going direct. I am open to acquiring in this space [wealth management],” he says. Asia is also a target for expansion, not only because of Bird’s experience in the region. Heng An Standard Life, a joint venture between SLA and Tianjin TEDA International, was granted approval last month to launch pension investment products in China, the first foreign venture to receive this permission. “Asia is in my blood. I never thought I would work anywhere else. China and India will be at the heart of future wealth accumulation. Asia will be a very big part of our story,” he says. He plays acoustic guitar for relaxation and watches developments in hi-fi music technology, an interest that developed during his training as a mechanical engineer. “Engineering teaches you the importance of precision,” he says. SLA’s investors and policyholders will be watching to see whether Bird’s precision plans yield results.
mcunliffe1: 1carus, This share buy-back has been in progress for a lengthy period of time. Back in March, 26th to be precise, I posted the following: MCunliffe1 - 26 Mar 2020 - 09:39:06 - 2319 of 2453 Standard Life SLA - SLA A simple example. A company is deemed to be worth, say, £100 and is known to have cash assets of, say, £10. The company embarks upon a share buy-back and uses £5 of the £10 cash assets buying up its own shares and then cancelling them. At the end of the process the company is deemed to be worth £95 as it's spent £5 of the £10 cash. In theory, the lesser number of shares in circulation represent a lower valued company, so should be 5% lower in value. However, we are talking very small percentages of shares in this buy-back. Some shares were being bought at £3.33 just before Christmas and at £1.77 three days ago. Almost half-priced. I maintain that SLA could have used the cash more productively had they bought other company's shares - ie. acted as a true Investment Company. That said, buying their own shares when the price is at a historic low point makes sense but only if you stop when the price starts to rise. Continue again when the share falls back to that same or a worse low point. Dec 2018 was a low point, Feb 2019 again, March 2019 was slightly better, but low and Aug 2019 also low. But, they continued to spend the cash even as a prolonged rise in the share price occured between Sept 2019 and Feb 2020. Don't tell me that was a result of the share buy-back because practically every other company in the market was seeing rising S.P.'s during that same period. C.I. likes Novacyt. Had SLA also liked Novacyt and bought THEIR shares instead of their own they'd have seen a 1200+% increase - since JANUARY 2020. That's what investment companies are supposed to do - invest in rising stars. I think it's rich for an investment company to buy-back its own, under-performing shares when there's so many better places for OUR money.
spud: How will a pivot to passive affect Standard Life’s share price? Opto 03 Dec 2020, 13:15 GMT Standard Life Aberdeen’s [SLA.L] share price began the year at 330.50p before falling by almost 50% to 174p on 23 March. As the pandemic spooked its clients, many switched to lower fee passive funds. The lifting of lockdown in the UK and hopes of an economic bounce back helped Standard Life’s share price hit 281.10p on 8 June, but the stock slumped again, hitting 208.90p on 25 September after disappointing first-half results in early August. Standard Life’s share price continued to plateau even after new boss Stephen Bird arrived in September, reaching just 257.20p on 12 November. In an interview with Bloomberg on 12 November, Bird said he planned to build a portfolio of passive products in order to stem investor outflows and respond to growing demand for index investing. Ultimately, the hope will be that this can, in turn, boost Standard Life’s share price. “Passive is an essential component of a full solution provider. We are screening for which technology, which people, which capabilities can help us get there,” Bird said. “An ideal active-passive split would be 70/30. If you stay as an old traditional asset class asset manager, you will be extinct.” As of 30 November, Standard Life’s share price climbed 6.8% to 274.80p. Reversing course Despite only 32% of its investments lagging their benchmark compared with 40% last year, Standard Life Aberdeen reported a drop in pre-tax profit to £195m down from £280m. Fee-based revenue of £706m was down from £815m. Its assets under management and administration dropped 6% to £512bn, hit by Lloyds Banking Group’s [LLOY] decision to switch £25bn of investments to rival Schroders. Keith Skeoch, in his last results as chief executive of Standard Life, painted a gloomy picture. “The outlook for markets is tough. I don’t think this recovery without a vaccine is going to be V-shaped, it’s going to be W-shaped,” he said. "The outlook for markets is tough. I don't think this recovery without a vaccine is going to be V-shaped, it's going to be W-shaped" - Keith Skeoch, former Standard Life CEO Following the statements from Bird, however, it is expected that Standard Life will build up more index linked exchange-traded funds, buy ETF technology and boost investments in assets such as infrastructure. Some analysts are sceptical about the chances of success for Standard Life’s share price. “It will be quite a challenge to achieve this,” Numis Securities analyst David McCann told Financial News. “Bearing in mind that BlackRock [BLK], Vanguard [VOO] and State Street [STT] have a 20-30 plus year head start, and certain European competitors like Legal & General [LGEN], DWS [DWS], HSBC [HSBA] and Amundi [AMUN] also are well experienced in this market, it is really hard to see how this might work.” Brand power Prior to Bird’s comments, Standard Life had received a Sell recommendation from five analysts rating the stock, with five offering a Hold rating and three a Buy, according to Marketbeat. The average target for Standard Life’s share price is 253.33p. Barclays rated it Underweight and gave it a 240p price target. Royal Bank of Canada rated it an Underperform and gave it a 225p price target. JPMorgan has an Overweight rating and a 270p target on Standard Life’s share price, stating that it has room to reduce its dividend payout in 2020/21 to a 7% yield — still leaving it ahead of the 3.5% average for FTSE 100 stocks — and to make acquisitions in its investment unit. There is also hope that Standard Life’s share price will gain from investing in wealth management services. “[Standard Life Aberdeen] is the fourth-largest wealth management business in the UK. It has failed to capitalise on this during the past few years,” Rupert Hargreaves wrote in The Motley Fool. “Wealth management can offer higher profits than fund management. Further, Standard Life is one of the most trusted financial brands in the country, which should give it an edge over competitors.” He added that the combination of its dividend yield and potential earnings expansion from new growth initiatives means Standard Life’s share price could produce large total returns in the years ahead. Market cap £6.302bn Operating margin (TTM) 53.49% EPS (TTM) -39.80 Quarterly revenue growth (YoY) -19.00% Standard Life's share price vitals, Yahoo Finance, 3 December 2020 spud
spud: Standard Life Aberdeen wants to compete with BlackRock in ETFs: ‘It will be quite a challenge’ BlackRock, Vanguard and State Street have a 20- to 30-year headstart in the ETF space, which in Europe alone has swelled to assets worth more than $1.1tn Standard Life Aberdeen chief executive Stephen Bird has plans to launch SLA into the ETF market. By David Ricketts Wednesday November 18, 2020 12:01 am Standard Life Aberdeen’s new chief executive has been in the top job for just over two months, but he already has grand plans about how he wants to transform the £511bn asset manager to compete with some of the world’s largest passive players. Former Citigroup executive Stephen Bird, who took over at the helm from Keith Skeoch in September, said he wants to propel SLA into the booming exchange traded funds sector, which at the end of September had assets of more than $1.1tn in Europe alone. SLA is known for its stock-picking capabilities. However, Bird has indicated the ideal active-passive split he wants to achieve is 70:30, according to an interview with Bloomberg on 12 November. “We can either buy proprietary ETF technology, buy an ETF business or build it,” he said. A spokesperson for SLA pointed to its acquisition of the US business of commodity ETF provider ETF Securities in 2018, where assets have doubled to $6bn. “Work is underway to build upon this success, by delivering our research and analytical strengths via ETFs,” said the spokesperson. However, analysts say making a concerted push into the ETF sector might be a tall order for the Edinburgh-headquartered asset manager, which has seen assets plummet from £660bn in 2017. “It will be quite a challenge to achieve this,” said David McCann, an analyst with Numis Securities. McCann said the biggest factor for success in the passive investment sector was possessing significant scale, due to the low fees index tracking products charge. Dominant players in the ETF sector also have significant muscle. BlackRock, the world’s largest asset manager, oversees $490bn in ETF assets in Europe. The top three ETF providers in the region have control of more than 62% of the market. “Bearing in mind that BlackRock, Vanguard and State Street have a 20-30 plus year headstart, and certain European competitors like L&G, DWS, HSBC and Amundi also are well experienced in this market, it is really hard to see how this might work,” said McCann. McCann added that an acquisition is likely to be the only way Bird can achieve his goal of launching SLA into the ETF business. “However, if the ratio is 70:30, and assuming the current business were to stay the same, this implies that the passive business they’d be looking to achieve would be [around £200bn] in size,” said McCann. “That is still tiny compared to the passive businesses being run by BlackRock, Vanguard, State Street, L&G [and others].” Tom Mills, an analyst with Jefferies, added the push into passives and ETFs with the ambition of building this capability to 30% of assets from scratch “is likely to come as a surprise to the market given competitive dynamics in that segment necessitate tremendous scale”. Mills said Lyxor — one of Europe’s largest ETF providers with around $84bn of assets and which is reportedly up for sale — could be a potential buying opportunity for SLA. Martin Gilbert, former vice-chair of SLA, told Financial News in August that Bird was likely to pursue deals to help build the asset manager. “Stephen will be really good on the organic growth front and on some selective M&A,” Gilbert said in August. “He has the strength of the balance sheet to build whatever he wants. I don’t think he’s taken the job to stand still.” Peter Sleep, a portfolio manager at Seven Investment Management who invests in ETFs, said building up a passive business would not be impossible for SLA, given its previous experience managing around £30bn in passive assets for Scottish Widows, before this was pulled in 2019. But significant scale would be needed in order to make profits, particularly in the ETF sector. “It is really hard to compete against BlackRock, State Street and Vanguard: the market megaliths. Margins are wafer thin and competition is intense,” said Sleep. “There are obviously lots of smaller players that they could buy, just for the experienced people to give a smoother start into ETFs,” he added. Nick Hyett, an equity analyst at Hargreaves Lansdown, said in order to succeed SLA will have to offer something existing ETF players do not. “Since passive funds should, at least in theory, be more or less identical in what they invest in, the only real differentiator is price,” said Hyett. “Really you need scale to compete on price, so its difficult to see how a fledgling SLA ETF offer could compete on that basis.” spud
mcunliffe1: Nick - I posted this a week or so ago on another SLA thread: thought it may be helpful to any who haven't read it previously. With a bit of time to kill I have been looking back at the share purchase numbers at SLA. The share buy-back started at about 14th August 2018. The share price was about 373p at that time and there were approx. 2979,559,515 shares in existance. At 30th Aug 2019 the share price was 249p and the number at 2400,929,435. They'd purchased about 19% of their shares by that point. At 31 Aug 2020 the share price was about 237p, the number of shares at 2241,101,532 and that means they'd bought about 6.6% of the shares available in the last year. In total, they've bought a little below 25% of the shares that were in existance at the outset in Aug 2018. The share price has of course plunged from 373 to 237 in that period. A drop of 36%. A week ago, the share price was at 225 so since the start of buy-back we've seen a share price drop of almost 40%. I'm trying to think positive here and wonder what the share price might have been without the buy-back. But, I'm thinking that the 75% of shares that exist now compared to the 100% at August 2018 hold a far lower value per share. If profits can be maintained the divi should be safe - but then, if the belief that profits could be maintained would a much lower number of shares not attract a higher value? Mad world. UPDATE: Since I wrote the above the share price has jumped appreciably - partly in response to the COVID-19 potential vacine.
mcunliffe1: With a bit of time to kill I have been looking back at the share purchase numbers at SLA. The share buy-back started at about 14th August 2018. The share price was about 373p at that time and there were approx. 2979,559,515 shares in existance. At 30th Aug 2019 the share price was 249p and the number at 2400,929,435. They'd purchased about 19% of their shares by that point. At 31 Aug 2020 the share price was about 237p, the number of shares at 2241,101,532 and that means they'd bout about 6.6% of the shares available in the last year. In total, they've bought a little below 25% of the shares that were in existance at the outset in Aug 2018. The share price has of course plunged from 373 to 237 in that period. A drop of 36%. Today, the share price is at 225 so since the start of buy-back we've seen a share price drop of almost 40%. I'm trying to think positive here and wondcer what the share price might have been without the buy-back. But, I'm thinking that the 75% of shares that exist now compared to the 100% at August 2018 hold a far lower value per share. If profits can be maintained the divi should be safe - but then, if the belief that profits could be maintained would a much lower number of shares not attract a higher value? Mad world.
spud: Shares in insurance companies are holding firm despite a high court ruling this month that they could have to pay out thousands. In the judgement, the court ruled that some insurers would have to pay out to businesses claiming business interruption due to the pandemic. However, as City AM reports, investors in Legal and General [LGEN], Aviva [AV] and Standard Life [SLA] “shook off the ruling”. What’s more remarkable is that many had predicted the insurance sector would be one of the hardest hit by the outbreak, paying out on both business and life insurance policies. Yet, while half-year profits have seen sharp falls, the sector seems resilient. Unlike banking, which has seen share prices suppressed since the outbreak, insurers have by and large managed to claw back some losses. So, what’s the outlook for heavyweights Legal and General, Aviva and Standard Life’s share prices for the rest of the year? Legal and General’s share price While Legal and General’s share price has been on a downward trajectory since mid-August, it's still lightyears above the 138.6p it was trading at on 23 March. Causing the late summer slip were first-half pre-tax profits of £285m, a steep 73% drop from the same period last year. Weighing on earnings were historically low-interest rates and payouts on life insurance policies, both due to the coronavirus. £285MILLION LEGAL & GENERAL'S HALF-YEAR PRE-TAX PROFITS - A 73% YOY DECLINE Still, that didn't stop Legal and General from paying out a 4.93p per share first-half dividend. While that's less than some analysts were expecting, considering that the regulator has been pressuring insurers to freeze payouts to shore up capital, it’s better than nothing. For income-seeking investors, some analysts reckon dividends will be back to strength sooner rather than later. Gordon Aitken, an analyst at RBC Capital Markets, said: “We see this dividend caution as merely temporary and not an indication that dividend growth will slow.” Among the analysts tracking the stock, Legal and General's share price carries a 288.79p price target, which would see a 59.6% upside on 21 September’s closing price if hit. “We see this dividend caution as merely temporary and not an indication that dividend growth will slow” - Gordon Aitken, RBC Capital Markets analyst Aviva’s share price Two months into the job and Aviva's new CEO Amanda Blanc has picked up £1m worth of the insurer's stock. Picking up 324,887 Aviva shares at just over 300p certainly shows self-belief in her own turnaround strategy. Having replaced Maurice Tulloch in the top spot after the former CEO resigned for family health reasons, Blanc has the task of turning around Aviva's share price, which has fallen 30% since the start of the year. 30% AVIVA'S YTD SHARE PRICE DROP To do this, Blanc has pledged to focus on Aviva’s core UK, Ireland and Canada markets, while reducing its European and Asian operations. Already Blanc has overseen the sale of Aviva's Singapore operations to Singapore Life for $1.98bn in one of the biggest insurance deals in Southeast Asia. “The sale of Aviva Singapore is a significant first step in our new strategy to bring greater focus to Aviva’s portfolio,” said Blanc. The deal also got the blessing from analysts at Jefferies, who described it as constituting “exceptional value creation” for Aviva, while commending Blanc for showing “decisive action”. So, a promising start from the new CEO, with the possibility of having picked up Aviva’s share price at a bargain? Analysts tracking the stock on Yahoo Finance have a 551.33p average price target. Hitting this would see an impressive 95.3% upside on Aviva’s current share price (as of 21 September’s close). “The sale of Aviva Singapore is a significant first step in our new strategy to bring greater focus to Aviva’s portfolio” - Aviva's new CEO Amanda Blanc Standard Life Aberdeen’s share price Like Aviva, Standard Life’s share price has seen a steep drop off since the start of the year, followed by a mild recovery since the start of the pandemic. In half-year results, adjusted pre-tax profit came in at £195m, down 30% from the £280m seen in the same period last year. The sharp downturn in profit can be notched up to both the coronavirus and the loss of its business with Lloyds bank. In total, net withdrawals came in at £24.8bn, causing fee revenue to drop 13%. Despite the losses, Standard Life rewarded shareholders with a 7.3p interim dividend. £195MILLION STANDARD LIFE'S HALF-YEAR PRE-TAX PROFITS - A 30% YOY DECLINE Presiding over his last set of results, the outgoing CEO Keith Skeoch commented that “the long-term consequences of the crisis will be profound,” and predicted that any economic recovery would be W-shaped without a vaccine. While that struck a gloomy chord, Standard Life actually saw overall outflows slow, excluding the withdrawal paid to Lloyds. If the asset manager continues to reduce outflows, Standard Life’s share price may have already been through the worst. Analysts have pinned a 380.07p average target on Standard Life’s share price, which would see a 75% gain on the current share price (through 21 September’s close). spud
mcunliffe1: There haven't been many days other than nasty of late Salty. No matter how much of our money this company spends on share buy-backs, paying-off old CEO's, saying "hello" generously to new CEO's and F.D.'s the share price seems mired. It's am unglamorous outfit in all respects and until that changes and good news starts to appear I cannot see the situation changing. I recently posted (on the other thread I think) the comparison between SLA and Hargreaves Lansdown in respect of inward investment: HL - £7,700m SLA - £ 100m For the 12months to 30June2020. That's why the SLA share price is languishing IMO.
mcunliffe1: Wanting to check the progress (or lack therein) of my pension, I log on to the SLA site to be shocked by the headline value of my pension. It's lost several thousand over the past couple of days. A closer inspection shows the following statement: "At this time, the above values do not include any adjustments or bonuses." No explanation why. No confirmation when this may change. Hence, accurate valuation. THIS is part of the reason SLA share price is sh*t. The management care little for the customer; their level of disrespect is unacceptable. This has been the case for several years and I suspect it will not improve.
Standard Life Aberdeen share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Standard L..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210412 23:27:29